3Sata M, Nishimatsu H, Suzuki E, et al. Endothelid nitric oxide synthase is essential for HMG - CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia FASEBJ,2001,15: 2530 - 2532. 被引量：1
4Weis M, Heeschen C, Glassford A J, et al. Statins have biphasic effects on angiogenesis. Circulation,2002,105:739 - 745. 被引量：1
5Kureishi Y,Luo Z, Shiojima I, et al. The HMG - CoA reductase inhibitor simvastain activates the protein Kinase Akt and promotes anglogenesis in normocholesterolemic animal. Nat Med,2000,6:1004-1010. 被引量：1
6Karas RH. Statin use enhances coronary collaterals[ J], Am Heart J, 2003,146:876 - 881. 被引量：1
7Laufs U, Gertz K, Dirnagl U, et al. Rosuvastation, a new HMG - CoA reductase inhibitor,upregulates endothelial, nitric oxide synthase and protects from is chemic stroke in mice[J]. Brain Res,2002,942( 1 - 2) :23 -30. 被引量：1
8Koichi T,Masaaki H,Toshikazu T,Anti - apoptotic effect of atorvastatin, a 3 - Hydroxy - 3 - methylglutary 1 coenzyme A reductase inhibitor, on cardiac rnyocytes through protein kinase C activation Clin Exp Pharmacol Physiol,2004,31:360 - 367. 被引量：1
9Ito M ,Adachi T,Pimentel DR,et al. statins inhibit betaadrenergic receptor - stimulated apoptosis in adult rat ventricular myocytes via a Racl - depengent mechanism circulation,2004,110:412 - 418. 被引量：1
10Laufs U. Endres M, Stagliano N, et al. Neclroprotection mediated by changes in the endothelial actin cytoskeleton. [J]. Clin Invest, 2000,106 : 15 - 24. 被引量：1
二级参考文献28
1Bauersachs J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J]. Circulation, 2001 被引量：1
2Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction [J]. Circulation, 2002, 105:868 被引量：1
3Patel R, Nagueh SF, Tsybouleva N, et al. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy [J]. Circulation, 2001,104:317 被引量：1
4Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors [J]. Circulation, 1998, 97:1129. 被引量：1
5Oi S, Haneda T, Osaki J, et al. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells [J]. Eur J Pharmacol, 1999, 376:139 被引量：1
6Luo JD, Zhang WW, Zhang GP, et al. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis [J]. Clin Exp Pharmacol Physiol, 1999, 26:903 被引量：1
7Dechend R, Fiebeler A, Park JK, et al. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor [J]. Circulation, 2001,104:576 被引量：1
8Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages[J]. Arterioscler Thromb Vasc Biol, 2003, 23:769 被引量：1
9Ikeda U, Shimpo M, Ohki R, et al. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells [J]. Hypertension, 2000, 36:325 被引量：1
10Bellosta S, Via D, Canavesi M, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J]. Arterioscler Thromb Vasc Biol, 1998, 18:1671 被引量：1
